Dilip Jeste, M.D.
Name, Degree: Dilip V. Jeste, M.D.
Role(s) in Task Force and Work Group: Chair, Workgroup on Dementia, Delirium, & Amnestic and Other Cognitive Disorders; Study Group on Psychiatric/General Medical Interface
Institutional Affiliation(s): University of California, San Diego, and VA San Diego Healthcare System
City, State: San Diego, CA
Biographical Sketch:
Dr. Jeste is the Estelle and Edgar Levi Chair in Aging, director of the Sam and Rose Stein Institute for Research on Aging, and Distinguished Professor of psychiatry and neurosciences at the University of California, San Diego, and at the Department of Veterans Affairs San Diego Healthcare System. He is also director of Advanced Center for Intervention and Services Research, which is funded by the National Institute of Mental Health (NIMH) and focuses on schizophrenia and other psychoses in late life, and director of the John A. Hartford Center of Excellence in Geriatric Psychiatry.
Dr. Jeste obtained his medical education in Poona and Bombay, India, and completed his psychiatry residency at Cornell, his neurology residency at George Washington University, and his research fellowship at NIMH.
Dr. Jeste is the recipient of multiple honors and awards and federal research grants. He has published seven books and more than 500 articles and chapters in peer-reviewed journals and books. He is a member of the Institute of Medicine of the National Academy of Sciences and of the National Advisory Mental Health Council of the National Institutes of Health. He is the editor-in-chief of the American Journal of Geriatric Psychiatry, and he is in the ISI list of the “world’s most cited authors”—comprising less than 0.5% of all publishing researchers in the past two decades.
Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V : Three calendar years before nomination and Each year thereafter through the present calendar year. (For 2008, activities to date and commitments for remainder of year.)
|
Non-Profit and Advocacy Organizations |
Year(s) |
Role |
|
International College of Geriatric Psychoneuropharmacology |
2003-08 |
Past President, Member of Council |
|
NAMI |
2003-2005 |
Scientific Advisory Council |
The two tables below represent Dr. Jeste’s disclosure of significant interests and affiliations for: (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.
Dr. Jeste has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, his aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.
|
KEY NUMBER: 1. Consultation Fees (include scientific advisory boards) 2. Full- or Part-time Employee 3. Industry-related Grant-Research Support received or pending 4. Honoraria (includes Speakers’ Bureau) 5. Stock or other financial options |
6. Expert testimony 7. Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product) 8. Patents received or pending 9. Officer, director/trustee, executive (specify) 10. Other (specify) |
Disclosure of significant interests including: Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
Abbott |
2005 |
4 |
|
AstraZeneca |
2003 |
1,4 |
|
Bristol-Myers Squibb |
2003-06 |
1,4 |
|
Eli Lilly |
2003-04 |
1,4 |
|
Janssen |
2003-06 |
1,4, 10 (Unrestricted educational supplement to an NIH-funded research training grant) |
|
Novartis |
2003 |
1 |
|
Pfizer-Eisai |
2003 |
1,4 |
|
Solvay-Wyeth |
2003-06 |
1.4 |
|
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen |
2003-06 |
10 (Donation of medication for an NIH-funded grant) |
|
Alamo |
2004-2005 |
1 |
|
Otsuka |
2003-2006 |
1, 4 |
|
Best Practices, Inc. |
2006 |
4 |
|
American Journal of Geriatric Psychiatry |
2003-2006 |
10 (editor) |
Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
AstraZeneca |
2007 |
10 (Honoraria for an industry-sponsored symposium at the annual meeting of the American Association for Geriatric Psychiatry) |
|
Janssen
|
2007 |
10 (Honoraria for an industry-sponsored symposium at the annual meeting of the American Psychiatric Association) |
|
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen |
2007-2008 |
10 (Donation of medication for an NIH-funded grant) |